These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8035320)

  • 21. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
    Johansson A; Liu L; Holmgren S; Burcher E
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors.
    Parlani M; Conte B; Majmone S; Maggi CA; Rovero P; Giachetti A
    J Urol; 1990 Dec; 144(6):1543-5. PubMed ID: 2172570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus.
    Barthó L; Lénárd L; Patacchini R; Halmai V; Wilhelm M; Holzer P; Maggi CA
    Neuroscience; 1999 Apr; 90(1):221-8. PubMed ID: 10188948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
    Ellis JL; Undem BJ; Kays JS; Ghanekar SV; Barthlow HG; Buckner CK
    J Pharmacol Exp Ther; 1993 Oct; 267(1):95-101. PubMed ID: 8229792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
    Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
    Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
    Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
    Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization with a selective agonist discriminates between multiple tachykinin receptors.
    Laufer R; Gilon C; Chorev M; Selinger Z
    J Pharmacol Exp Ther; 1988 May; 245(2):639-43. PubMed ID: 2835478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potent and selective agonist for NK-2 tachykinin receptor.
    Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
    Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth muscle neurokinin-2 receptors mediate contraction in human saphenous veins.
    Mechiche H; Grassin-Delyle S; Pinto FM; Buenestado A; Candenas L; Devillier P
    Pharmacol Res; 2011 May; 63(5):414-22. PubMed ID: 21272642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
    Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence for the existence of NK2 tachykinin receptor subtypes.
    Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
    Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
    Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
    Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
    Zeng XP; Burcher E
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum.
    Takahashi R; Nishimura J; Hirano K; Naito S; Kanaide H
    Br J Pharmacol; 2002 Nov; 137(6):845-54. PubMed ID: 12411416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists.
    Deal MJ; Hagan RM; Ireland SJ; Jordan CC; McElroy AB; Porter B; Ross BC; Stephens-Smith M; Ward P
    J Med Chem; 1992 Oct; 35(22):4195-204. PubMed ID: 1331460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tachykinin regulation of airway smooth muscle cell proliferation.
    Noveral JP; Grunstein MM
    Am J Physiol; 1995 Sep; 269(3 Pt 1):L339-43. PubMed ID: 7573467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
    Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
    Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bidirectional regulation of human colonic smooth muscle contractility by tachykinin NK(2) receptors.
    Nakamura A; Tanaka T; Imanishi A; Kawamoto M; Toyoda M; Mizojiri G; Tsukimi Y
    J Pharmacol Sci; 2011; 117(2):106-15. PubMed ID: 21946672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.